Immune Response to Salmonella Location, Location, Location? by Hughes, Eric A & Galán, Jorge E
Immunity, Vol. 16, 325–328, March, 2002, Copyright 2002 by Cell Press
MinireviewImmune Response to Salmonella:
Location, Location, Location?
toskeleton rearrangements leading to the uptake of the
bacteria into a membrane-bound compartment. In addi-
tion, activation of Cdc42 and Rac leads to the repro-
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gramming of gene expression in the infected intestinalNew Haven, Connecticut 06536
epithelial cells, ultimately resulting in the production of
a variety of proinflammatory cytokines. Remarkably,
these bacteria are actively engaged in the reversion ofSuccessful immunity against Salmonella infections is
the cellular responses stimulated by the initial interac-dependent on the generation of CD4 T helper cells
tion. Through the injection of a GTPase-activating pro-and to a lesser extent on antibody production and CD8
tein (GAP) for Cdc42 and Rac, Salmonella effectivelyT cells. The cells within the lymphatic tissue of the gut
halts the responses resulting from the activation of theseare likely to be central for the orchestration of a proper
GTPases, contributing to the recovery of the host celland rapid response. The anatomical restriction of the
and thus preserving the integrity of its replicative nichepathogen may also determine the distribution of ef-
(Fu and Gala´n, 1999). These complex interactions thatfector cells. In this issue of Immunity, McSorley et
occur during the initial stages of infection are not onlyal. address both of these processes using identifiable
an eloquent example of the sophistication of the biologyCD4 T cells that are specific for Salmonella typhimu-
of these bacteria but also a demonstration that theserium. Such cells localize to the Peyer’s patches of the
microorganisms are active participants in the host/small intestine when the bacteria are delivered orally.
pathogen interaction.
The actual primary site at which Salmonella breaches
the intestinal epithelium has not been precisely defined,Salmonella enterica are enteropathogenic bacteria that
and it is a matter of some controversy (Gala´n and Sanso-can cause a variety of syndromes ranging from common
netti, 1996). It is nevertheless clear that the site of entryfood poisoning to the sometimes life-threatening typhoid
is dependent on both the serovar of the infecting Salmo-fever. The type of disease caused by these bacteria de-
nella as well as the species of the infected host. It ispends not only on the serovar (e.g., S. typhimurium,
often cited in textbooks that in humans the distal partS. typhi, S. enteritidis, etc.) of the infecting bacteria but
of the small bowel is the primary site of Salmonellaalso on the species and immunological status of the
infection. However, there is remarkably little direct evi-infected hosts (Ohl and Miller, 2001). Despite the wide-
dence to support this assertion. In other animals, thespread nature of this pathogen, it is often overlooked
involvement of other segments of the intestinal tractthat the overwhelming majority of Salmonella infections
is well documented. There is also some controversyare subclinical. Indeed, Salmonella has evolved a very
regarding the role of Peyer’s patches as a site of entrycomplex functional interphase with its hosts, the prod-
for Salmonella. The follicle-associated epithelium (FAE)uct of evolution throughout its long-standing associa-
overlying the Peyer’s patches contains specialized cells,tion with vertebrate animals (Gala´n, 2001). This func-
designated M cells (“M” for microfolds or membranoustional interphase, which is beginning to be understood
cells). These cells have increased pinocytic activity andin great detail at the molecular level, is best character-
deliver microbes and antigen via transepithelial vesicu-ized by its refinement rather than by its potential for
lar transport from the gut lumen to macrophages and
harm. It is now clear that Salmonella engages its host
lymphocytes residing below the epithelium. Although it
in remarkable biochemical interactions that lead to a
is well demonstrated that at least in some animal models
series of well-coordinated cellular responses. These cel- Salmonella can replicate in Peyer’s patches (Jones et
lular responses allow the bacteria to reach privileged al., 1994), it is also well documented that Salmonella
niches, where they can replicate and complete their life can breach the intestinal barrier through the cells of the
cycle within the host. columnar epithelium (Takeuchi, 1967). In fact, it has been
After oral infection, usually through contaminated argued that since these cells vastly outnumber intestinal
food or water, Salmonella can survive exposure to the M cells, they may well constitute the main port of entry
low pH of the stomach and arrive in the intestine where it for Salmonella. Once the intestinal barrier has been
can penetrate the epithelial layer (Gala´n and Sansonetti, breached, the fate of Salmonella varies widely de-
1996). This phase of the Salmonella life cycle is largely pending on its serovar or the species of the infected
dependent on the function of a specialized protein deliv- host. In most cases, Salmonella remains localized to the
ery system (termed type III), which “injects” bacterial intestinal epithelium and the gut-associated lymphoid
proteins into the host cell with the capacity to specifi- tissues. In rare cases, Salmonella becomes systemic
cally stimulate or inhibit cellular responses. A subset of and invades deeper tissues.
these proteins stimulates the activity of the Rho family The innate immune system plays an essential role in
GTPases Cdc42 and Rac by either directly catalyzing the early responses to Salmonella and in most subclini-
nucleotide exchange or by stimulating endogenous ex- cal infections may be enough to control progression
change factors (Gala´n, 2001). As a result of this activa- to disease (Lalmanach and Lantier, 1999; Ma¨kela¨ and
tion, intestinal epithelial cells undergo profuse actin cy- Hormaeche, 1997). The importance of macrophages and
polymorphonuclear neutrophils in the early responses
to Salmonella is well documented (O’Brien et al., 1979;1Correspondence: jorge.galan@yale.edu
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Vassiloyanakopoulos et al., 1998). The stimulation of depending on the profile of cytokines they secrete. TH1
cells produce IFN- and TNF- and activate cellular im-proinflammatory cytokine production (e.g., TNF-, IL-1,
IL-6, IL-8, IL-12, etc.) by agonists of Toll receptors (e.g., munity and inflammation, while TH2 cells produce IL-4,
IL-5, and IL-13 and induce B cell activation and differen-LPS, lipoprotein, flagellin, etc.) and by specific bacterial
effectors delivered by Salmonella through its type III tiation. A number of studies have shown that Salmonella
infection results in the induction of a TH1 response (Piesecretion system is also likely to be an important compo-
nent of this phase of the defense response (Gala´n, 2001; et al., 1997; Thatte et al., 1993). It has also been shown
that administration of exogenous IFN- to mice has bac-Lalmanach and Lantier, 1999). Although the innate im-
mune system is the primary line of defense against Sal- teriostatic effects and that neutralization of endoge-
nously produced IFN- by specific antibodies increasesmonella infections, it is clear that the acquired immune
system is important for clearing the infection as well as the mortality of mice infected with S. typhimurium (Mat-
sumura et al., 1990; Ramarathinam et al., 1991). Thesefor providing effective protection to subsequent chal-
lenge with related Salmonella strains. Most of what is results, in combination with the observation that mice
deficient in IFN- receptors are highly susceptible toknown about the immune response to Salmonella comes
from studies using a mouse model of infection (Mit- Salmonella infection (Hess et al., 1996), further support
a crucial role for CD4 TH1 cells in Salmonella protection.trucker and Kaufmann, 2000). Although this model ex-
hibits the obvious advantage of the ease with which In addition to T cell-mediated immunity, the produc-
tion of antibody has been proposed to be important inmice can be genetically manipulated, it has the limitation
that it does not faithfully replicate the natural infection. mediating immunity to Salmonella, and there have been
many studies that have presented evidence supportingFor example, in humans, Salmonella typhimurium usu-
ally causes a self-limiting diarrhea (food poisoning). In a role for B cells and antibody production in conferring
protection (Ma¨kela¨ and Hormaeche, 1997; Mastroeni etcontrast, in the mouse, Salmonella typhimurium causes
a systemic infection that resembles typhoid fever in hu- al., 1993, 2000). Salmonella infections result in potent
antibody responses, particularly to LPS. However, themans, a disease caused by S. typhi, a significantly differ-
ent serovar. In addition, while wild-type (Ityr) mice are contribution of antibodies to Salmonella immunity has
been controversial given conflicting findings after induc-relatively resistant to Salmonella typhimurium, the most
often utilized Itys mice are highly susceptible to S. typhi- tion of passive immunity by transfer of serum to naive
mice. It has been recently shown that mice with a tar-murium infection (O’Brien et al., 1980). These mice are
defective in the natural-resistance-macrophage-associ- geted disruption of the Ig gene (Igh-6/), which are
deficient in B cells, showed increased susceptibility toated protein 1 (Nramp-1) (Forbes and Gros, 2001). Be-
cause of the increased susceptibility of these mice, most Salmonella infection and an inability to mount a strong
convalescent immune response (Mastroeni et al., 2000).studies have been carried out using this genetic back-
ground, which certainly complicates the extrapolation Therefore, it appears that B cells may influence the lon-
gevity or quality of the T cell-mediated responses.of these findings to the understanding of the immune
response to Salmonella during natural infection. Further- Despite these significant advancements in the under-
standing of Salmonella acquired immunity, it is still notmore, some studies have been conducted using unnatu-
ral routes of infection (e.g., intravenous or intraperito- known where T cells first encounter antigen-presenting
cells bearing MHC/Salmonella antigen peptide com-neal) or using attenuated strains of S. typhimurium,
which has led to inconsistent results. Despite these plexes. Dendritic cells located in Peyer’s patches and
other areas of the intestinal tract are the prime candi-complications and caveats, experiments conducted
with specific gene-deficient mice have been very valu- dates to be responsible for first sampling Salmonella
antigens, since these bacteria are most often restrictedable in contributing to the understanding of the immune
response to Salmonella (Mittrucker and Kaufmann, to this anatomical site during natural infection (with the
exception of the serovars capable of causing typhoid2000).
There is general consensus about the importance of fever such as S. typhi) (Yrlid et al., 2001). In fact, studies
have suggested that dendritic cells are capable of takingT cells in acquired immunity to Salmonella (Ma¨kela¨ and
Hormaeche, 1997; Mittrucker and Kaufmann, 2000). up Salmonella directly from the lumen of the intestinal
tract (Rescigno et al., 2001). Some studies have shownNude mice and mice deficient in  T cells are more
susceptible to Salmonella infections. However, the rela- rapid translocation of S. typhimurium to deeper tissues
(Vazquez-Torres et al., 1999), suggesting that perhapstive contribution of the different T cell subsets has been
a matter of some controversy. In most cases, CD4 T antigen-presenting cells located at sites distant from
the intestinal epithelium could come in contact with Sal-cells have been shown to be more important than CD8
T cells, particularly in adoptive transfer experiments monella antigens very early during infection. However,
these studies have been carried out in strains of mice(Mastroeni et al., 1992; Nauciel, 1990). Consistent with
an important role for CD4 cells, MHC class II-deficient that are highly susceptible to Salmonella infections due
to the deficiency in the macrophage-associated proteinmice showed increased susceptibility to Salmonella
(Hess et al., 1996). However, evidence indicates that N-ramp. Such high susceptibility introduces a major ca-
veat in the interpretation of these experiments, sinceCD8 cells also contribute to the protective immune
response to Salmonella since in at least one report, the pathogenesis of Salmonella is undoubtedly very dif-
ferent in these mice and the anatomic restrictions in the2m-deficient mice were shown to be more susceptible
to Salmonella infection (Lo et al., 1999; Mastroeni et al., generation of the immune response may be significantly
affected. In a study investigating the role of TH1 cells in1992; Nauciel, 1990). Nevertheless, it is clear that CD4
T cells play a more prominent role in immunity to Salmo- S. typhimurium immunity, orally infected mice showed
T cell responses in the Peyer’s patches (George, 1996).nella. CD4 helper T cells (TH) are divided into two types
Minireview
327
However, parenterally inoculated mice did not show 2000). Salmonella typhimurium, for example, expresses
different sets of genes for the initial interaction withsuch a response. Only when these mice were rechal-
lenged were T cell responses detected in Peyer’s the intestinal epithelium than those utilized to cause
systemic infection (Gala´n, 2001). Although it has notpatches. From these results, it was concluded that Sal-
monella could elicit a TH1 response in Peyer’s patches been specifically investigated, it is entirely possible or
even likely that flagellin is not expressed by Salmonellaand mesenteric lymph nodes and that priming of T cells
could occur at other nonmucosal sites, but only orally when it reaches the spleen. Indeed, it has been shown
that flagellar gene expression is negatively regulatedadministered Salmonella could direct T cell activity to
the lymphatic tissue of the gut. These studies also un- by the PhoP/PhoQ bacterial two-component regulatory
system (Adams et al., 2001). Since this regulatory systemderscored the importance of utilizing the natural route
of infection in the study of the immune response to an plays a prominent role during systemic infection, it is
indeed very likely that genes negatively regulated byintestinal pathogen.
In this issue of Immunity, McSorley et al. report the PhoP/PhoQ are turned off during this phase of the infec-
tion (Groisman, 2001). This is the case, for example, forvery intriguing observation that Salmonella typhimurium
induces a very localized mucosal CD4 T cell response the genes that encode the type III secretion system that
Salmonella utilizes during its initial interaction with theafter oral inoculation despite the fact that the experimen-
tal conditions utilized were such that led to a dissemin- intestinal epithelium (Gala´n, 2001). This system, which
is coregulated with the flagellar system (Eichelberg andated infection (McSorley et al., 2002). An adoptive trans-
fer system was used to monitor the distribution and fate Gala´n, 2000) and also negatively regulated by PhoP/
PhoQ (Pegues et al., 1995), is switched off during theof flagellin-specific CD4 T cells after S. typhimurium
infection of highly susceptible N-ramp-deficient mice. systemic phase of infection. Therefore, it is possible that
the lack of expansion of flagellin-specific CD4 cells inThey observed a remarkably rapid activation (within 3
hr after oral infection) of CD4 T cells in the Peyer’s the spleen may simply be the consequence of lack of
flagellin expression by the systemically localized bacte-patches of orally inoculated mice. Although this rapid
activation kinetics may be in part due to the rather mas- ria. Experiments with bacteria constitutively expressing
the test antigen will be necessary to rule out this possibil-sive bacterial doze used in these studies (50,000
LD50), this observation does underscore the rapidity ity. The authors also argue that in the spleen, Salmonella
and the adoptively transferred T cells may reside inand efficiency with which Salmonella is capable of en-
gaging the immune system. These results also under- different compartments, which may contribute to the
anatomical separation between relevant APCs andscore the often overlooked fact that bacterial patho-
gens, unlike inert antigens, are active participants in CD4 T cells and the lack of expansion of those cells.
However, it has been previously shown that Salmonellathe induction of host responses and therefore have the
potential to modulate (negatively or positively) the kinet- is indeed capable of stimulating Salmonella-specific
CD4 T cells in the spleens of infected mice when paren-ics of the immune response. This rapid activation also
suggests that dendritic cells in T cell areas of Peyer’s terally administered (George, 1996). Therefore, it would
have to be argued that Salmonella ends up in a differentpatches must be able to rapidly present antigen to
nearby T cells without migrating to the mesenteric lymph spleen area when parenterally administered, which is
unlikely based on what is known about its systemicnodes, as has been traditionally proposed. McSorley et
al. also observed a strict anatomical compartmentaliza- dissemination through the bloodstream. A significant
difference in the experimental set up that resulted intion of activated flagellin-specific CD4 cells. Activated
CD4 cells were observed almost exclusively in Peyer’s expansion of CD4 T cells in the spleen upon Salmonella
infection is that the indicator antigens used in thosepatches and mesenteric lymph nodes, and no clonal
expansion was observed in other systemic anatomical studies (bacterial extracts) were certainly expressed by
Salmonella when localized in the spleen. Despite thissites including spleen and other lymphoid organs. This
is indeed a surprising finding since there was significant caveat (and perhaps because of it), McSorley et al. con-
vincingly show that CD4 cells stimulated at mucosalbacterial load at these systemic sites. McSorley et al.
hypothesize that their findings may indicate that there sites such as Peyer’s patches migrate inefficiently to
systemic sites (McSorley et al., 2002). In contrast, whenis a rather strict anatomical compartmentalization be-
tween APCs and T cells, creating an anatomical barrier adoptively transferred mice were immunized intrave-
nously with LPS and flagellin peptide, CD4 flagellin-that prevents T cell activation. Although this hypothesis
may well be correct, it is important to point out that specific T cells were detected throughout all compart-
ments, including mesenteric lymph nodes, liver, andthere is an alternative explanation for these findings.
Although the bacterial load in systemic organs was sig- lamina propria. McSorley et al.’s observations contrast
those reported by Huleatt et al., who showed that oralnificant, this does not necessarily mean that the anti-
genic load (i.e., levels of flagellin) was equivalent. The and parenteral immunization of mice with Listeria mono-
cytogenes resulted in an essentially identical distribu-authors state that APC from spleens were apparently
able to stimulate a flagellin-specific T cell in vitro. How- tion of bacterial peptide-specific CD8 T cells through-
out the spleen, intestinal epithelium, as well as theever, it is possible that the number of flagellin-loaded
APCs was sufficient to obtain a read out on a sensitive lamina propria (Huleatt et al., 2001). However, since mice
are not permissive for Listeria monocytogenes replica-in vitro assay but was not enough to significantly expand
the adoptively transferred T cells to a level detectable tion in the intestinal epithelium, it is likely that this experi-
mental set up was simply not capable of resolving poten-by the experimental methods used. It is very well estab-
lished that bacterial pathogens rapidly reprogram gene tial differences in the immune response after oral or
parental inoculation.expression during their infection cycle (Mahan et al.,
Immunity
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Thatte, J., Rath, S., and Bal, V. (1993). Int. Immunol. 5, 1431–1436.Therefore, it appears that the location of the infection
Vassiloyanakopoulos, A.P., Okamoto, S., and Fierer, J. (1998). Proc.may determine the characteristics of the subsequent
Natl. Acad. Sci. USA 95, 7676–7681.effector response to microbial infections. Future studies
Vazquez-Torres, A., Jones-Carson, J., Baumler, A.J., Falkow, S.,will have to rigorously consider the role of the anatomical
Valdivia, R., Brown, W., Le, M., Berggren, R., Parks, W.T., and Fang,restriction of the replicating pathogen, the levels of anti-
F.C. (1999). Nature 401, 804–808.
gen expression in different compartments, as well as
Yrlid, U., Svensson, M., Kirby, A., and Wick, M.J. (2001). Microbesthe active role that pathogens may play in modulating
Infect. 3, 1239–1248.
the immune response.
Selected Reading
Adams, P., Fowler, R., Kinsella, N., Howell, G., Farris, M., Coote, P.,
and O’Connor, C.D. (2001). Proteomics 1, 597–607.
Eichelberg, K., and Gala´n, J.E. (2000). Infect. Immun. 68, 2735–2743.
Forbes, J.R., and Gros, P. (2001). Trends Microbiol. 9, 397–403.
Fu, Y., and Gala´n, J.E. (1999). Nature 401, 293–297.
Gala´n, J.E. (2001). Annu. Rev. Cell Dev. Biol. 17, 53–86.
Gala´n, J.E., and Sansonetti, P.J. (1996). In Escherichia coli and Sal-
monella typhimurium: Cellular and Molecular Biology, Second Edi-
tion., F.C. Neidhardt, ed. (Washington D.C.: American Society for
Microbiology Press), pp. 2757–2763.
George, A. (1996). Infect. Immun. 64, 4606–4611.
Groisman, E.A. (2001). J. Bacteriol. 183, 1835–1842.
Hess, J., Ladel, C., Miko, D., and Kaufmann, S.H. (1996). J. Immunol.
156, 3321–3326.
Huleatt, J.W., Pilip, I., Kerksiek, K., and Pamer, E.G. (2001). J. Immu-
nol. 166, 4065–4073.
Jones, B.D., Ghori, N., and Falkow, S. (1994). J. Exp. Med. 180,
15–23.
Lalmanach, A.C., and Lantier, F. (1999). Microbes Infect. 1, 719–726.
Lo, W.F., Ong, H., Metcalf, E.S., and Soloski, M.J. (1999). J. Immunol.
162, 5398–5406.
Mahan, M.J., Heithoff, D.M., Sinsheimer, R.L., and Low, D.A. (2000).
Annu. Rev. Genet. 34, 139–164.
Ma¨kela¨, P.H., and Hormaeche, C.E. (1997). In Host Response to
Intracellular Pathogens, S.H.E. Kaufman, ed. (Austin, TX, R.G.
Lndes), pp. 143–166.
Mastroeni, P., Villarreal-Ramos, B., and Hormaeche, C.E. (1992).
Microb. Pathog. 13, 477–491.
Mastroeni, P., Villarreal-Ramos, B., and Hormaeche, C.E. (1993).
Infect. Immun. 61, 3981–3984.
Mastroeni, P., Simmons, C., Fowler, R., Hormaeche, C.E., and Dou-
gan, G. (2000). Infect. Immun. 68, 46–53.
Matsumura, H., Onozuka, K., Terada, Y., Nakano, Y., and Nakano,
M. (1990). Int. J. Immunopharmacol. 12, 49–56.
McSorley, S.J., Asch, S., Costalonga, R., Reinhardt, L., and Jenkins,
M.K. (2002). Immunity 16, this issue, 365–377.
Mittrucker, H.W., and Kaufmann, S.H. (2000). J. Leukoc. Biol. 67,
457–463.
Nauciel, C. (1990). J. Immunol. 145, 1265–1269.
O’Brien, A.D., Rosenstreich, D.L., and Taylor, B.A. (1980). Nature
287, 440–442.
O’Brien, A.D., Scher, I., and Formal, S.B. (1979). Infect. Immun. 25,
513–520.
Ohl, M.E., and Miller, S.I. (2001). Annu. Rev. Med. 52, 259–274.
Pegues, D.A., Hantman, M.J., Behlau, I., and Miller, S.I. (1995). Mol.
Microbiol. 17, 169–181.
Pie, S., Truffa-Bachi, P., Pla, M., and Nauciel, C. (1997). Infect. Im-
mun. 65, 4509–4514.
Ramarathinam, L., Shaban, R.A., Niesel, D.W., and Klimpel, G.R.
(1991). Microb. Pathog. 11, 347–356.
Rescigno, M., Urbano, M., Valzasina, B., Francolini, M., Rotta, G.,
Bonasio, R., Granucci, F., Kraehenbuhl, J.P., and Ricciardi-Castag-
noli, P. (2001). Nat. Immunol. 2, 361–367.
Takeuchi, A. (1967). Am. J. Pathol. 50, 109–136.
